PharmAsia Market Study April 2000


USD 1,000.00

* Required Fields

USD 1,000.00


Be the first to review this product

Table of Contents

PharmAsia Market Study April 2000, April 2000 Market Study - Respiratory Diseases in ChinaOverview and ScopeOverview and ScopeMarket Engineering Analysis of the Chinese Asthma and Pulmonary TB Market (1996-2006)Market DefinitionsChallenges Facing the Asthma and Pulmonary TB Market in ChinaMarket Engineering Valuation and Revenue Forecasts (1996-2006)Market Engineering Research Analysis of the Asthma Therapy Market in China (1996-2006)Competitive StructureMarket Engineering Research Analysis of the Pulmonary Tuberculosis Therapy Market in China (1996-2006)Market Engineering Research Measurement SystemCompetitive StructureMarket Engineering Strategy for the Asthma and Pulmonary TB market in ChinaMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsTarget Doctors and Patient Population by Introducing Education Programs on Diseases and Therapy ChoicesNew Techniques Ensure Strong Competition for CompaniesDevelop New Drug Delivery Systems That Offer Ease-of-DosageOpt for Selective Alliances with Local Distributors

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.